Researchers at Ohio State University say they've made a breakthrough in the treatment of leukemia. They've found the drug Ibrutinib caused remission in every patient who took it during a clinical trial. The drug is on the fast track for Food and Drug Administration approval.
Federal Approval Of New Leukemia Drug Pending
Facebook Twitter LinkedIn Email